U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old




  • In US
  • 2022-12-08 14:53:02Z
  • By Reuters
 

(Reuters) - The U.S. Food and Drug Administration on Thursday authorized updated COVID-19 booster shots from Moderna and Pfizer and its partner BioNTech for children as young as 6 months of age.

The amended authorizations allow use of Moderna's bivalent shot in children 6 months through 5 years of age, while the Pfizer/BioNTech vaccine can be given to those aged 6 months through 4 years.

Pfizer's shot can be administered as the third shot for those eligible and have not completed their primary vaccination series, the agency added.

(Reporting by Khushi Mandowara and Bhanvi Satija in Bengaluru; Editing by Sriraj Kalluvila)

COMMENTS

More Related News

'Various safety concerns': Why the FDA declined to regulate CBD as a food or supplement

The FDA's action comes after repeated calls from lawmakers, advocates and consumer groups for CBD to be allowed in foods and supplements.

Weak immune system? Government offers advice to help at-risk people avoid COVID-19 infections
Weak immune system? Government offers advice to help at-risk people avoid COVID-19 infections

The Food and Drug Administration officially announced that Evusheld is no longer authorized to prevent SARS-CoV-2 infection in the US.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US